James M. Boyett

James M. Boyett publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where James M. Boyett sits on this spectrum.

James M. Boyett D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where James M. Boyett sits on this spectrum.

Research.com Recognitions

• 1997 - Fellow of the American Statistical Association (ASA)

Best Publications

• Treating childhood acute lymphoblastic leukemia without cranial irradiation.

  Ching Hon Pui;Dario Campana;Deqing Pei;W. Paul Bowman

  1388
  Citations

• Metastasis Stage, Adjuvant Treatment, and Residual Tumor Are Prognostic Factors for Medulloblastoma in Children: Conclusions From the Children's Cancer Group 921 Randomized Phase III Study

  Paul M. Zeltzer;James M. Boyett;Jonathan L. Finlay;A. Leland Albright

  953
  Citations

• Treatment of Children With Medulloblastomas With Reduced-Dose Craniospinal Radiation Therapy and Adjuvant Chemotherapy: A Children's Cancer Group Study

  Roger J. Packer;Joel Goldwein;H. Stacy Nicholson;L. Gilbert Vezina

  732
  Citations

• Intellectual Outcome After Reduced-Dose Radiation Therapy Plus Adjuvant Chemotherapy for Medulloblastoma: A Children’s Cancer Group Study

  M. Douglas Ris;Roger Packer;Joel Goldwein;Dana Jones-Wallace

  618
  Citations

• Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy

  Packer Rj;Sutton Ln;Elterman R;Lange B

  597
  Citations

• Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia.

  William E. Evans;Mary V. Relling;John H. Rodman;William R. Crom

  579
  Citations

• Methods to Detect P-Glycoprotein-associated Multidrug Resistance in Patients' Tumors: Consensus Recommendations

  William T. Beck;Thomas M. Grogan;Cheryl L. Willman;Carlos Cordon-Cardo

  507
  Citations

• Multiagent Chemotherapy and Deferred Radiotherapy in Infants With Malignant Brain Tumors: A Report From the Children’s Cancer Group

  J. Russell Geyer;Richard Sposto;Mark Jennings;James M. Boyett

  435
  Citations

• Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group

  Patricia L. Robertson;Paul M. Zeltzer;James M. Boyett;Lucy B. Rorke

  418
  Citations

• Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group

  J L Finlay;J M Boyett;A J Yates;J H Wisoff

  398
  Citations

• Secondary brain tumors in children treated for acute lymphoblastic leukemia at St Jude Children's Research hospital

  Andrew W. Walter;Michael L. Hancock;Ching Hon Pui;Melissa M. Hudson

  348
  Citations

• Low-Stage Medulloblastoma: Final Analysis of Trial Comparing Standard-Dose With Reduced-Dose Neuraxis Irradiation

  Patrick R.M. Thomas;Melvin Deutsch;James L. Kepner;James M. Boyett

  347
  Citations

• Expression of p53 and prognosis in children with malignant gliomas.

  Ian F. Pollack;Sydney D. Finkelstein;Jeffrey Woods;Judith Burnham

  301
  Citations

• A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study

  Anuradha Banerjee;Regina I. Jakacki;Arzu Onar-Thomas;Shengjie Wu

  293
  Citations

• Low-grade astrocytoma: a decade of experience at St. Jude Children's Research Hospital.

  Amar Gajjar;Robert A. Sanford;Richard Heideman;Jesse J. Jenkins

  290
  Citations

• Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital.

  C. H. Pui;J. M. Boyett;G. K. Rivera;M. L. Hancock

  288
  Citations

• Adenocarcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer.

  James E. Montie;David P. Wood;J. Edson Pontes;James M. Boyett

  281
  Citations

• Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Childrens Cancer Group.

  J R Geyer;P M Zeltzer;J M Boyett;L B Rorke

  276
  Citations

• TEL gene rearrangement in acute lymphoblastic leukemia: a new genetic marker with prognostic significance.

  J. E. Rubnitz;J. R. Downing;C. H. Pui;S. A. Shurtleff

  272
  Citations

• Carboplatin and Vincristine Chemotherapy for Children with Newly Diagnosed Progressive Low-Grade Gliomas

  R J Packer;J Ater;J Allen;P Phillips

  1
  Citations